Aperture Venture Partners is a venture capital firm based in New York, specializing in early-stage investments primarily within the healthcare and healthy living sectors. The firm focuses on a range of industries, including biopharmaceuticals, medical devices, healthcare IT and services, diagnostics, and drug discovery. Additionally, it invests in companies that promote healthy living through products and services related to personal care, weight management, and wellness. Aperture typically invests between $1 million and $5 million in its portfolio companies, seeking to lead investment rounds while also participating alongside other investors. With over 30 years of experience in healthcare and investment, the firm has successfully invested more than $1 billion and has been involved in founding companies that have collectively generated revenues exceeding $1 billion.
MASSACHUSETTS CAPITAL RESOURCE COMPANY was established in 1977 as a limited partnership privately owned and funded by Massachusetts-based life insurance companies. The Company’s mission was to create a source of risk capital to fill the senior debt to equity funding “gap” experienced by growing companies. Their investment activity complements, rather than competes with, the financing provided by senior lenders and equity investors. Mass. Capital provides higher risk growth and acquisition capital to manufacturing, distribution, service and technology companies. They focus on emerging growth and middle market companies with operations in Massachusetts. Their investments are structured to fit the specific needs of portfolio companies and to complement funding available from senior lenders and equity investors.
Cadence Design Systems, Inc. (Cadence) develops electronic design automation (EDA), software, hardware, and silicon intellectual property (IP). Cadence licenses software and IP, sells or leases hardware technology and provides engineering and education services worldwide to help manage and accelerate electronics product development processes. The Company’s customers use its products and services to design and develop complex integrated circuits (ICs) and electronics systems. The Company combines its products and technologies into platforms for four design activities: Functional Verification; Digital IC Design and Implementation; Custom IC Design and Verification, and System Interconnect Design. It sells software using three license types: subscription, term and perpetual. In June 2010, Cadence acquired Denali Software, Inc. (Denali). In May 2011, it acquired Altos Design Automation, Inc. On July 11, 2011, the Company acquired Azuro, Inc.
Dream Incubator is a Tokyo-based strategic consulting and business development firm established in 2000, focusing on early-stage investments across the Asia-Pacific, Western Europe, and the United States. The firm primarily serves Japanese corporate clients and governmental institutions, offering both capital and professional services to support the growth and expansion of next-generation companies. In addition to its consulting services, Dream Incubator actively invests in various business stages and operates its own ventures. The firm also provides assistance in developing capital policies and business plans, particularly for companies in high-tech and IT sectors. With additional offices in China, Singapore, and Vietnam, Dream Incubator aims to foster innovation and entrepreneurship in the region.
Speedinvest is a European venture capital firm based in Vienna, Austria, founded in 2011. It focuses on early-stage investments in technology-related companies, targeting sectors such as fintech, insurtech, deep tech, and consumer tech. The firm typically invests between €250,000 and €3 million, aiming for minority stakes of up to 20% in its portfolio companies. Speedinvest emphasizes operational support and seeks to collaborate closely with entrepreneurs, often taking on operational roles for six months to a year. With a network that extends to Silicon Valley, Speedinvest positions itself as a pivotal investment and development hub within Europe’s start-up ecosystem, actively investing in Central and Eastern European markets including Austria, Germany, and the UK.
Lumira Ventures is a well-established venture capital firm with a focus on healthcare and life sciences investments in North America. Founded in 1989, the firm collaborates with entrepreneurial management teams to support the development of biotherapeutic and medical device companies addressing significant unmet needs. With offices in Toronto, Montreal, Vancouver, and Boston, Lumira Ventures has a strong portfolio of over 100 healthcare companies, actively investing in over 30 companies in Canada and the United States. The firm provides strategic guidance, financing, and market access to help maximize the value of technology pipelines for its portfolio companies.
Spiral Capital is a venture capital firm with multiple entities focusing on seed, early, middle, and late-stage investments in mobile, internet, software, healthcare, industrials, transportation, emerging technologies, and various other sectors in Southeast Asia, Japan, and the United States. Founded in 2012 as IMJ Investment Partners, it later transformed into Spiral Ventures to operate independently. With offices in Singapore, Jakarta, and Tokyo, Spiral Capital aims to support startups and innovative companies in their growth journey across different markets in East Asia and the Asia-Pacific region.
As one of the largest and most active venture capital fund partners in Central and Eastern Europe our mission is to create new ways of equity funding for innovative small and medium-sized enterprises with high growth potential as well as more traditional businesses for the purpose of establishing a sustainable and competitive SME and enterprise ecosystem both in Hungary and in the region
Longwall Venture Partners is an Oxford-based venture capital firm founded in 2011, specializing in growth capital, early stage, and start-up investments in the science, healthcare, and technology sectors in the United Kingdom. They focus on investing in a variety of industries including physical science, life science, security, media, business software, and engineering.
Agate Medical Investments LP, founded in 2007 and based in Tel Aviv, specializes in mid-venture, late-stage, and buyout investments in mature companies within the medical technology and specialized healthcare sectors. The firm focuses on supporting companies innovating in diagnostics, prevention, treatment of serious illnesses, medical devices, healthcare services, and initiatives related to healthcare infrastructure. With a strategic emphasis on life sciences, healthcare, and technology-related companies primarily in Israel and South Korea, Agate Medical Investments aims to drive growth and innovation in the healthcare industry.